Quarterly Activities/Appendix 5B Cash Flow Report
Released
Latest announcements
Announcement summary
Quarterly Activities/Appendix 5B Cash Flow Report
A good quarter with an MRE update, revised development pathway and material advancements on product definition and approvals whilst completing an enhanced scoping study. All underpinned by a successful capital raise in a difficult market.
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask RareX a question about this announcement.